Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Stanton

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Journal of Medicinal Chemistry|November 12, 1993
Substituted chromenes as potent, orally active 5-lipoxygenase inhibitorsY Satoh, J L Stanton, A J Hutchison, et al.
The New England Journal of Medicine|May 26, 1999
Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapyM R Furtado, D S Callaway, J P Phair, et al.
The American Journal of Clinical Nutrition|April 1, 1981
Food eating patterns and health: a reexamination of the Ten-State and HANES I surveysH S Schwerin, J L Stanton, A M Riley, et al.
Biochemistry and Molecular Biology International|December 1, 1993
Effects of metalloprotease inhibitors on the conversion of proendothelin-1 to endothelin-1A J Trapani, J L Balwierczak, R W Lappe, et al.
Journal of Medicinal Chemistry|February 17, 1995
Synthesis and structure-activity relationships of oxamic acid and acetic acid derivatives related to L-thyronineN Yokoyama, G N Walker, A J Main, et al.
Journal of Medicinal Chemistry|June 8, 2000
Anilides of (R)-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinaseG R Bebernitz, T D Aicher, J L Stanton, et al.
Journal of Medicinal Chemistry|January 29, 2000
Secondary amides of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinaseT D Aicher, R C Anderson, J Gao, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of Medicinal Chemistry|November 12, 1993
Substituted chromenes as potent, orally active 5-lipoxygenase inhibitorsY Satoh, J L Stanton, A J Hutchison, et al.
The New England Journal of Medicine|May 26, 1999
Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapyM R Furtado, D S Callaway, J P Phair, et al.
The American Journal of Clinical Nutrition|April 1, 1981
Food eating patterns and health: a reexamination of the Ten-State and HANES I surveysH S Schwerin, J L Stanton, A M Riley, et al.
Biochemistry and Molecular Biology International|December 1, 1993
Effects of metalloprotease inhibitors on the conversion of proendothelin-1 to endothelin-1A J Trapani, J L Balwierczak, R W Lappe, et al.
Journal of Medicinal Chemistry|February 17, 1995
Synthesis and structure-activity relationships of oxamic acid and acetic acid derivatives related to L-thyronineN Yokoyama, G N Walker, A J Main, et al.
Journal of Medicinal Chemistry|June 8, 2000
Anilides of (R)-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinaseG R Bebernitz, T D Aicher, J L Stanton, et al.
Journal of Medicinal Chemistry|January 29, 2000
Secondary amides of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinaseT D Aicher, R C Anderson, J Gao, et al.
Pageof 4